RIBOSCIENCE
Ribo Science shapes public policy, drive business solutions and grow Californias life sciences.
RIBOSCIENCE
Industry:
Association Biotechnology Information Technology Non Profit
Founded:
2012-01-01
Address:
Sacramento, California, United States
Country:
United States
Website Url:
http://www.riboscience.com
Total Employee:
11+
Status:
Active
Contact:
(202) 743-7566
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps Microsoft Azure DNS US Privacy User Signal Mechanism
Current Employees Featured
Founder
Official Site Inspections
http://www.riboscience.com Semrush global rank: 5.82 M Semrush visits lastest month: 1.43 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "RiboScience"
Riboscience LLC
Riboscience applies specialized chemistry and biology to create novel treatments for human diseases. We particularly focus on building ribose-based molecules and we use structure โฆSee details»
Management - Riboscience LLC
The Riboscience leadership team has over 50 years of combined expertise that spans the research and development spectrum, from drug discovery and development to drug approval, โฆSee details»
RiboScience - Crunchbase Company Profile & Funding
Ribo Science shapes public policy, drive business solutions and grow Californias life sciences. There is no recent news or activity for this profile. View contacts for RiboScience to access โฆSee details»
Riboscience - LinkedIn
Riboscience is a clinical stage biotechnology company developing treatments for serious infectious diseases and cancer. We apply ribose and structure-guided design technologies to the discovery...See details»
Riboscience Company Profile - Office Locations, Competitors
Riboscience is a biotechnology company developing therapeutics for human diseases. It develops ribose-based molecules for the treatment of hepatitis C, influenza, oncology, and other diseases.See details»
Riboscience LLC - VentureRadar
Website: https://www.riboscience.com/ Riboscience applies specialized chemistry and biology to create novel treatments for human diseases. The company particularly focus on building โฆSee details»
Riboscience - Overview, News & Similar companies - ZoomInfo
Dec 7, 2022ย ยท View Riboscience (www.riboscience.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
RBS-2418 - Drug Targets, Indications, Patents - Synapse
RBS2418 (investigational product) is a specific immune modulator, working through ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1), designed to lead to anti-tumor immunity by increasing endogenous 2'-3'-cyclic โฆSee details»
About โ Riboscience LLC
Riboscience applies specialized chemistry and biology to create novel treatments for human diseases. We particularly focus on building ribose-based molecules and we use structure โฆSee details»
RBS-3165 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024ย ยท RBS-3165, Initially developed by Riboscience LLC, Now, its global highest R&D status is Discovery, Therapeutic Areas: Infectious Diseases,Respiratory Diseases, Active โฆSee details»
Programs - Riboscience LLC
Riboscience is developing a small molecule treatment of HBV infection with the potential to fully suppress HBV replication in the liver, increase cure rates and reduce the incidence of HBV-associated severe liver disease and liver cancer.See details»
Program Guide โ ASCO Meeting Program Guide - American โฆ
ENPP1 inhibition protects cGAMP and ATP and reduces adenosine levels in the tumor microenvironment, activates antigen-presenting cells and increases T-cell infiltration promoting โฆSee details»
RIBOSCIENCE ESMO PRESENTATION HIGHLIGHTS SAFETY, PK, PD โฆ
Oct 20, 2023ย ยท Riboscience is a private clinical-stage biotechnology company leveraging a proprietary library of nucleoside and non-nucleoside analogs to rationally design drug โฆSee details»
Riboscience ESMO presentation highlights safety, PK
Oct 20, 2023ย ยท Riboscience is a private clinical-stage biotechnology company leveraging a proprietary library of nucleoside and non-nucleoside analogs to rationally design drug โฆSee details»
Science โ Riboscience LLC
Riboscience combines unique specialist chemistry expertise with state-of-the-art structural biology approaches and the identification of novel protein targets to create new classes of cancer โฆSee details»
1025MO Preliminary safety, pharmacokinetics and โฆ
ENPP1 inhibition protects cGAMP and ATP from hydrolysis, reduces adenosine levels in the TME, activates APCs and increases T-cell infiltration promoting antitumor immunity. RBS2418, โฆSee details»
RBS-3149 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 8, 2024ย ยท Understand key drug designations in just a few clicks with Synapse. RBS-3149, Initially developed by Riboscience LLC, Now, its global highest R&D status is Discovery, โฆSee details»
Riboscience LLC (Riboscience LLC) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่ โฆ
The clinical study is proceeding into a dose-expansion phase. About Riboscience, LLC Riboscience is a private clinical-stage biotechnology company leveraging a proprietary library โฆSee details»
ESMO โ Riboscience LLC
Dec 8, 2022ย ยท Riboscience applies specialized chemistry and biology to create novel treatments for human diseases. We particularly focus on building ribose-based molecules, and we use โฆSee details»
News - Riboscience LLC
Please check out the latest Riboscience news. Riboscience ESMO presentation highlights safety, PK, PD and efficacy data from the first 19 patients of the ENPP1 inhibitor RBS2418 Phase 1 โฆSee details»